Insights from a proteomic atlas of human Alzheimer's disease brain tissue  

作　　者：Tomas Kavanagh Eleanor Drummond 

机构地区：[1]Brain and Mind Centre and School of Medical Sciences,University of Sydney,Camperdown,NSW,Australia

出　　处：《Neural Regeneration Research》2025年第3期799-800,共2页中国神经再生研究（英文版）

基　　金：supported by the Bluesand Foundation;TDM Foundation;Faculty of Medicine and Health, University of Sydney (FMH EMCR Emerging Star Grant), NIH (P01AG060882) to ED。

摘　　要：There is an urgent need to identify new drug targets for Alzheimer's disease(AD). While new immunotherapies show promise, clinical benefit appears low, and side effects are high. A greater understanding of the disease mechanisms driving AD is an essential factor that will facilitate the identification of new, effective drug targets.

关 键 词：ALZHEIMER CLINICAL driving 

分 类 号：R749.16[医药卫生—神经病学与精神病学]